A-2121X

N/A

Report date: 2025/01/26 17:48:34

Base Information

Drug NameA-2121X
Drug Alias NameA-2121X
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic peripheral neuropathyPainNeuralgia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZyvran Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesZyvran Pharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathyPainNeuralgia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A